Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination
Issue Cover
Current Issue
Volume 1,
Issue 1,
March 2024
View This Issue

Latest Articles

CD302 predicts achievement of deep molecular response in chronic myeloid leukemia patients treated with imatinib
Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells
Competition of dual SF3B1mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells
Saliva as a feasible alternative to blood for interrogation of somatic hematopoietic variants
The landscape of rare genetic variants in familial Waldenström macroglobulinemia

Advertisement

Featured Content

KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study

Real-world comparison of daratumumab-based regimens in relapsed/refractory multiple myeloma using health record data

Comparison of TP53 mutations in myelodysplasia and acute leukemia suggests divergent roles in initiation and progression

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 

Advertisement

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement